Editor in Chief: Johannes Czernin, MD
University of California–Los Angeles
Founded in 1960, The Journal of Nuclear Medicine (JNM) is the world’s leading nuclear medicine, molecular imaging and theranostics journal, accessed more than 11 million times each year by practitioners around the globe, providing them with the information they need to advance this rapidly expanding field. JNM includes hot topics and state-of-the-art reports as well as clinical and basic science research in oncology, theranostics, neurology, cardiology, and radiation biology.
According to new data announced by Clarivate in the 2021 Journal Citation Reports™ (released in June 2022), JNM ranks third in impact among 136 medical imaging journals worldwide.
Editor in Chief: Kathy S. Thomas, MHA, CNMT, PET, FSNMMI-TS
Battle Ground, WA
JNMT is the only peer-reviewed publication dedicated to nuclear medicine technology. Published quarterly, each issue features continuing education articles written by leading educators in nuclear medicine technology as well as news and updates on practice, licensure, and credentialing for nuclear medicine technologists. Current credentialing, continuing education and licensure requirements are reported regularly.
Practitioners from across the imaging sciences turn to JNMT for peer-reviewed information related to daily clinical practice, as well as:
SNMMI is an official sponsor of the journal Molecular Imaging, an open-access journal dedicated to publication of studies that combine recent advances in noninvasive imaging modalities with molecular and cellular biology in order to improve our understanding of normal and disease processes. Published by SAGE Journals; managed by Hindawi.
Editor in Chief: Henry F. VanBrocklin, PhD
University of California–San Francisco